Of the eight included studies, three assessed changes in hepatic fat content following GLP1-RA treatment, of which all reported correlations between weight loss and decreases in hepatic fat content (32, 35, 36), lending support for the role of weight loss on hepatic steatosis. This evidence concerns the gene GLP1R and fatty liver disease.